Cost-consequence analysis evaluating the use of botulinum neurotoxin-A in patients with detrusor overactivity based on clinical outcomes observed at a single UK centre. by Kalsi, V, Popat, R, Apostolidis, A, Kavia, R, Odeyemi, I, Dakin, H, Warner, J, Elneil, S, Fowler, C, Dasgupta, P